Stephen Simpson, CFA
Long only, growth at reasonable price, value, research analyst

Globus Medical Staying On A Growth Track

The world of spinal care continues to be divided among the slow-growing giants like Johnson & Johnson (NYSE:JNJ), Medtronic (NYSE:MDT), and Stryker (NYSE:SYK) and the much faster-growing up-and-comers like NuVasive (NASDAQ:NUVA) and Globus Medical (NYSE:GMED). With Globus maintaining a focus on continuous product development and new launches and the expansion of its sales effort, the growth prospects continue to look good, particularly as some industry headwinds appear to be abating.

Valuation for med-tech has gotten trickier as the stocks have been quite strong over the last year or so. Globus isn't so appealing from the viewpoint of intrinsic value (discounted cash flow), but the stock doesn't seem overpriced from the...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details